G-Medical Net enters supervised review while its Standard market move is assessed
The company said it could not confirm compliance with the Growth market's market-capitalisation maintenance standard by the end of its improvement period, so the stock will be designated under review from June 1. Trading is set to continue while Tokyo Stock Exchange assesses its application to move to the Standard market, which the company says it meets on its own calculations.